Traws Pharma, Inc. — Capital/Financing Update 2013

Jul 23, 2013

CORRESP 1 filename1.htm

July 23, 2013

United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549

Attention:
Austin Stephenson
Dan Greenspan
Jim Peklenk
Mark Brunhofer

Re: Onconova Therapeutics, Inc.

Registration Statement on Form S-1 (File No. 333-189358)

Ladies and Gentlemen:

In connection with the above-captioned Registration Statement, we wish to advise that between July 11, 2013 and the date hereof 1,170 copies of the Preliminary Prospectus dated July 11, 2013 were distributed as follows: 220 to prospective underwriters; 790 to institutional investors; 0 to prospective dealers; 160 to individuals; 0 to rating agencies and 0 to others.

We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, July 24, 2013 or as soon thereafter as practicable.

[ signature page follows ]

SEQ.=1,FOLIO='',FILE='C:\JMS\C901502\13-9590-8\task6143757\9590-8-bc.htm',USER='C901502',CD='Jul 23 04:57 2013'

Very truly yours,
Citigroup Global Markets Inc.
Leerink Swann LLC
As representatives of the
Prospective Underwriters
By:	Citigroup Global Markets Inc.
By:	/s/ Brian Gleason
	Name: Brian Gleason
	Title: Director
By:	Leerink Swann LLC
By:	/s/ Daniel Dubin
	Name: Daniel Dubin
	Title: Vice Chairman

Signature Page to Acceleration Request

SEQ.=1,FOLIO='',FILE='C:\JMS\C901502\13-9590-8\task6143757\9590-8-bc.htm',USER='C901502',CD='Jul 23 04:57 2013'